McKesson Corporation's Revenue by Segment
In fiscal year 2024, McKesson Corporation's revenue by segment (products & services) are as follows:
- International Segment: $14.13B
- Medical-Surgical Solutions Segment: $11.31B
- Prescription Technology Solutions: $4.77B
- U.S. Pharmaceutical Segment: $278.74B
Learn more about McKesson Corporation’s Revenue by Geography
Check out competitors to McKesson Corporation in a side-by-side comparison.
Explore additional financial metrics for McKesson Corporation.
| International Segment | 36345000000 |
|---|---|
| Medical-Surgical Solutions Segment | 11608000000 |
| Prescription Technology Solutions | 3864000000 |
| U.S. Pharmaceutical Segment | 212149000000 |
| International Segment | 20598000000 |
|---|---|
| Medical-Surgical Solutions Segment | 11110000000 |
| Prescription Technology Solutions | 4387000000 |
| U.S. Pharmaceutical Segment | 240616000000 |
| International Segment | 14130000000 |
|---|---|
| Medical-Surgical Solutions Segment | 11313000000 |
| Prescription Technology Solutions | 4769000000 |
| U.S. Pharmaceutical Segment | 278739000000 |
The above chart shows McKesson Corporation's revenue percentage share by segment (products and services).
In fiscal year 2022, McKesson Corporation's revenue by segment is as follows:
- International Segment generated $36.35B in revenue, representing 13.77% of its total revenue.
- Medical-Surgical Solutions Segment generated $11.61B in revenue, representing 4.4% of its total revenue.
- Prescription Technology Solutions generated $3.86B in revenue, representing 1.46% of its total revenue.
- U.S. Pharmaceutical Segment generated $212.15B in revenue, representing 80.37% of its total revenue.
The biggest segment for McKesson Corporation is the U.S. Pharmaceutical Segment, which represents 80.37% of its total revenue.
The smallest segment for McKesson Corporation is the Prescription Technology Solutions, which represents 1.46% of its total revenue.
The above chart shows McKesson Corporation's revenue percentage share by segment (products and services).
In fiscal year 2023, McKesson Corporation's revenue by segment is as follows:
- International Segment generated $20.60B in revenue, representing 7.44% of its total revenue.
- Medical-Surgical Solutions Segment generated $11.11B in revenue, representing 4.02% of its total revenue.
- Prescription Technology Solutions generated $4.39B in revenue, representing 1.59% of its total revenue.
- U.S. Pharmaceutical Segment generated $240.62B in revenue, representing 86.96% of its total revenue.
The biggest segment for McKesson Corporation is the U.S. Pharmaceutical Segment, which represents 86.96% of its total revenue.
The smallest segment for McKesson Corporation is the Prescription Technology Solutions, which represents 1.59% of its total revenue.
The above chart shows McKesson Corporation's revenue percentage share by segment (products and services).
In fiscal year 2024, McKesson Corporation's revenue by segment is as follows:
- International Segment generated $14.13B in revenue, representing 4.57% of its total revenue.
- Medical-Surgical Solutions Segment generated $11.31B in revenue, representing 3.66% of its total revenue.
- Prescription Technology Solutions generated $4.77B in revenue, representing 1.54% of its total revenue.
- U.S. Pharmaceutical Segment generated $278.74B in revenue, representing 90.22% of its total revenue.
The biggest segment for McKesson Corporation is the U.S. Pharmaceutical Segment, which represents 90.22% of its total revenue.
The smallest segment for McKesson Corporation is the Prescription Technology Solutions, which represents 1.54% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| International Segment | 13.77% | 7.44% | 4.57% |
| Medical-Surgical Solutions Segment | 4.4% | 4.02% | 3.66% |
| Prescription Technology Solutions | 1.46% | 1.59% | 1.54% |
| U.S. Pharmaceutical Segment | 80.37% | 86.96% | 90.22% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of McKesson Corporation.
In fiscal year 2024, the U.S. Pharmaceutical Segment generated the most revenue ($278.74B), and the Prescription Technology Solutions generated the least revenue ($4.77B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Products & Services | 2022 | 2023 | 2024 |
|---|---|---|---|
| International Segment | $36.35B - |
$20.60B
43.33%
|
$14.13B
31.40%
|
| Medical-Surgical Solutions Segment | $11.61B - |
$11.11B
4.29%
|
$11.31B
1.83%
|
| Prescription Technology Solutions | $3.86B - |
$4.39B
13.54%
|
$4.77B
8.71%
|
| U.S. Pharmaceutical Segment | $212.15B - |
$240.62B
13.42%
|
$278.74B
15.84%
|
| Total Revenue | $263.97B - |
$276.71B
4.83%
|
$308.95B
11.65%
|
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
-
Pfizer Revenue by Segment
-
Boston Scientific Corporation Revenue by Segment
-
Bristol-Myers Squibb Company Revenue by Segment
-
Cigna Corporation Revenue by Segment
-
Cardinal Health Revenue by Segment
-
Moderna Revenue by Segment
